+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Recombinant Proteins Manufacturing Services Market Size, Share & Trends Analysis Report, By Service Type (Pre-clinical & Clinical Services, Commercial Production), By Host Cell, By End-user, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2023
  • Region: Global
  • Grand View Research
  • ID: 5876150
Description Jump to:
The global recombinant proteins manufacturing services market size is expected to reach USD 12.74 billion by 2030, growing at a CAGR of 17.79% from 2023 to 2030. Recombinant proteins have many applications in the field of biotechnology research, and medicine. Furthermore, recombinant protein manufacturing is one of the effective procedures utilized in the life sciences sector, which has a significant impact on advanced healthcare.

The global healthcare industry is expanding rapidly, which promotes spending on research & development (R&D) to discover new treatments for a range of diseases. Recombinant protein production is closely associated with the expansion of the healthcare industry & spending on biologics. Furthermore, government support encouraged the research efforts of academic institutions along with biotechnological companies, resulting in the development of the market for proteins. For instance, in February 2023, The European Investment Bank (EIB), supported by the InvestEU program, agreed to provide USD 19.95 million (€18 million) in financing to the Estonian biopharmaceutical developer Icosagen AS to expand its drug discovery, development, and production capabilities.

Additionally, with the ongoing advancements in recombinant technology, novel applications of recombinant proteins for developing personalized medicine, cell & gene therapies, and bioengineering products are projected to increase. For instance, gene editing technologies, such as CRISPR-Cas9, have enabled the precise alteration of recombinant proteins to create innovative therapeutics. These factors are expected to significantly increase the demand for proteins, driving the market for manufacturing services.

Several companies offer recombinant protein production services, including Lonza, GenScript, Merck KGaA, Kaneka Eurogentec S. A., and ExcellGene SA., creating growth prospects for outsourcing activities. Key players are expanding their manufacturing capabilities to cater to the growing outsourcing demand across the globe. For instance, in October 2022, Merck KGaA opened a new commercial facility for its Millipore CTDMO Services in Martillac, France. The new 2,700 sq. m. facility was built for producing drug substances, including monoclonal antibodies and other recombinant proteins. Similarly, in September 2021, Aviva Systems Biology, a company that manufactures and develops antibodies, immunoassay kits, along with recombinant proteins for research in life sciences, launched an innovative protein-on-demand, customized protein investment portfolio for basic research as well as preclinical studies. Such initiatives are expected to create lucrative growth opportunities in the market over the coming decade.

Recombinant Protein Manufacturing Services Market Report Highlights

  • By service type, the commercial production servicessegment accounted for the largest share of 58.60% in 2022. This is attributed to the growing accessibility of high-yield expression systems
  • By host cell, the mammalian segment accounted for the largest share of 54.91% in 2022. The market is expanding due to growing demand for mammalian cells in pharmaceutical and biotech companies
  • By end-user, the pharmaceutical & biotechnology companies segment accounted for the largest share of 78.53% in 2022. Recombinant proteins gained immense traction in the biotechnology & pharmaceutical industries, where they can be utilized to create vaccines and treatments for various illnesses and protein manufacturing-related services
  • North America held the largest share of 37.86% in 2022. This is mostly due to the presence of major market participants and the rising cost of healthcare across regions


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Service Type Segment
1.2.2. Host Cell Segment
1.2.3. End-user Segment
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information Or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Increasing Adoption Of Outsourcing Models For Recombinant Protein Manufacturing
3.3.2. Increasing Scope Of Applications For Recombinant Protein-Based Products
3.3.3. Increasing Use Of Recombinant Proteins In Research-Use Activities
3.4. Market Restraint Analysis
3.4.1. Stringent Regulations Associated With Recombinant Protein-Based Biopharmaceuticals
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Service Type Business Analysis
4.1. Global Recombinant Proteins Manufacturing Services Market: Service Type Movement Analysis
4.2. Pre-clinical & Clinical Services
4.2.1. Pre-clinical & Clinical Services Market, 2018 - 2030 (USD Million)
4.3. Commercial Production Services
4.3.1. Commercial Production Services Market, 2018 - 2030 (USD Million)
Chapter 5. Host Cell Business Analysis
5.1. Global Recombinant Proteins Manufacturing Services Market: Host Cell Movement Analysis
5.2. Mammalian Cells
5.2.1. Mammalian Cells Market, 2018 - 2030 (USD Million)
5.3. Bacterial Cells
5.3.1. Bacterial Cells Market, 2018 - 2030 (USD Million)
5.4. Insect Cells
5.4.1. Insect Cells Market, 2018 - 2030 (USD Million)
5.5. Yeast & Fungi
5.5.1. Yeast & Fungi Market, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. End-User Business Analysis
6.1. Global Recombinant Proteins Manufacturing Services Market: End-User Movement Analysis
6.2. Pharmaceutical & Biotechnology Companies
6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
6.3. Academic & Research Institutes
6.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Global Recombinant Proteins Manufacturing Services Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. North America Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Regulatory Framework
7.2.2.4. Target Disease Prevalence
7.2.2.5. U.S. Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Regulatory Framework
7.2.3.4. Target Disease Prevalence
7.2.3.5. Canada Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.3.2. Germany
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. Target Disease Prevalence
7.3.2.5. Germany Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Target Disease Prevalence
7.3.3.5. UK Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Target Disease Prevalence
7.3.4.5. France Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Regulatory Framework
7.3.5.4. Target Disease Prevalence
7.3.5.5. Italy Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Regulatory Framework
7.3.6.4. Target Disease Prevalence
7.3.6.5. Spain Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Regulatory Framework
7.3.7.4. Target Disease Prevalence
7.3.7.5. Denmark Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Regulatory Framework
7.3.8.4. Target Disease Prevalence
7.3.8.5. Sweden Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Regulatory Framework
7.3.9.4. Target Disease Prevalence
7.3.9.5. Norway Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.3.10. Switzerland
7.3.10.1. Key Country Dynamics
7.3.10.2. Competitive Scenario
7.3.10.3. Regulatory Framework
7.3.10.4. Target Disease Prevalence
7.3.10.5. Switzerland Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.3.11. Netherlands
7.3.11.1. Key Country Dynamics
7.3.11.2. Competitive Scenario
7.3.11.3. Regulatory Framework
7.3.11.4. Target Disease Prevalence
7.3.11.5. Netherlands Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. Target Disease Prevalence
7.4.2.5. Japan Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Target Disease Prevalence
7.4.3.5. China Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. Target Disease Prevalence
7.4.4.5. India Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Target Disease Prevalence
7.4.5.5. South Korea Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Target Disease Prevalence
7.4.6.5. Australia Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. Target Disease Prevalence
7.4.7.5. Thailand Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Target Disease Prevalence
7.5.2.5. Brazil Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Target Disease Prevalence
7.5.3.5. Mexico Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Target Disease Prevalence
7.5.4.5. Argentina Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Target Disease Prevalence
7.6.2.5. South Africa Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Target Disease Prevalence
7.6.3.5. Saudi Arabia Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Target Disease Prevalence
7.6.4.5. UAE Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Target Disease Prevalence
7.6.5.5. Kuwait Recombinant Proteins Manufacturing Services Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Lonza
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Boehringer Ingelheim International GmbH
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. FUJIFILM Diosynth Biotechnologies
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Merck KGaA
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Bruker (InVivo BioTech Services GmbH)
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Sino Biological, Inc.
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. GenScript
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Kaneka Corporation (Kaneka Eurogentec S.A)
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Polyplus Transfection (Xpress Biologics)
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Boster Biological Technology
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. Trenzyme GmbH
8.4.11.1. Overview
8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
List of Tables
Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 Global Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 4 Global Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 5 Global Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 6 North America Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 7 North America Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 8 North America Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 9 North America Recombinant Proteins Manufacturing Services Market by Country, 2018 - 2030 (USD million)
Table 10 U.S. Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 11 U.S. Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 12 U.S. Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 13 Canada Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 14 Canada Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 15 Canada Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 16 Europe Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 17 Europe Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 18 Europe Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 19 Europe Recombinant Proteins Manufacturing Services Market by Country, 2018 - 2030 (USD million)
Table 20 UK Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 21 UK Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 22 UK Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 23 Germany Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 24 Germany Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 25 Germany Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 26 France Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 27 France Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 28 France Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 29 Italy Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 30 Italy Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 31 Italy Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 32 Spain Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 33 Spain Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 34 Spain Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 35 Denmark Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 36 Denmark Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 37 Denmark Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 38 Sweden Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 39 Sweden Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 40 Sweden Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 41 Norway Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 42 Norway Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 43 Norway Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 44 Switzerland Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 45 Switzerland Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 46 Switzerland Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 47 Netherlands Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 48 Netherlands Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 49 Netherlands Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 50 Asia Pacific Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 51 Asia Pacific Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 52 Asia Pacific Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 53 Asia Pacific Recombinant Proteins Manufacturing Services Market by Country, 2018 - 2030 (USD million)
Table 54 China Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 55 China Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 56 China Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 57 Japan Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 58 Japan Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 59 Japan Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 60 India Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 61 India Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 62 India Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 63 South Korea Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 64 South Korea Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 65 South Korea Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 66 Australia Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 67 Australia Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 68 Australia Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 69 Thailand Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 70 Thailand Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 71 Thailand Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 72 Thailand Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 73 Latin America Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 74 Latin America Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 75 Latin America Recombinant Proteins Manufacturing Services Market by Country, 2018 - 2030 (USD million)
Table 76 Brazil Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 77 Brazil Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 78 Brazil Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 79 Mexico Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 80 Mexico Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 81 Mexico Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 82 Argentina Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 83 Argentina Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 84 Argentina Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 85 Middle East & Africa Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 86 Middle East & Africa Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 87 Middle East & Africa Recombinant Proteins Manufacturing Services Market by Country, 2018 - 2030 (USD million)
Table 88 South Africa Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 89 South Africa Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 90 South Africa Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 91 Saudi Arabia Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 92 Saudi Arabia Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 93 Saudi Arabia Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 94 UAE Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 95 UAE Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD million)
Table 96 UAE Recombinant Proteins Manufacturing Services Market by End-User, 2018 - 2030 (USD million)
Table 97 Kuwait Recombinant Proteins Manufacturing Services Market by Service Type, 2018 - 2030 (USD million)
Table 98 Kuwait Recombinant Proteins Manufacturing Services Market by Host Cell, 2018 - 2030 (USD Million)
Table 99 Kuwait Recombinant Proteins Manufacturing Services Market By End-User, 2018 - 2030 (USD Million)
Table 100 Participant’s Overview
Table 101 Financial Performance
Table 102 Key Companies Undergoing Expansions
Table 103 Key Companies Undergoing Acquisitions
Table 104 Key Companies Undergoing Collaborations
Table 105 Key Companies Launching New Products/Services
Table 106 Key Companies Undergoing Partnerships
Table 107 Key Companies Undertaking Other Strategies
List of Figures
Figure 1. Market research process
Figure 2. Data triangulation techniques
Figure 3. Primary research pattern
Figure 4. Market research approaches
Figure 5. Value-chain-based sizing & forecasting
Figure 6. QFD modeling for market share assessment
Figure 7. Market formulation & validation
Figure 8. Market summary, 2022 (USD Million)
Figure 9. Market segmentation & scope
Figure 10. Market driver impact
Figure 11. Market restraint impact
Figure 12. Porter’s analysis
Figure 13. PESTEL analysis
Figure 14. Global recombinant proteins manufacturing services market: Service type outlook and key takeaways
Figure 15. Global recombinant proteins manufacturing services market: Service type movement analysis
Figure 16. Global pre-clinical & clinical services market, 2018 - 2030 (USD million)
Figure 17. Global commercial production services market, 2018 - 2030 (USD million)
Figure 18. Global recombinant proteins manufacturing services market: Host cell outlook and key takeaways
Figure 19. Global recombinant proteins manufacturing services market: Host cell movement analysis
Figure 20. Global mammalian cells market, 2018 - 2030 (USD million)
Figure 21. Global bacterial cells market, 2018 - 2030 (USD million)
Figure 22. Global insect cells market, 2018 - 2030 (USD million)
Figure 23. Global yeast & fungi market, 2018 - 2030 (USD million)
Figure 24. Global others market, 2018 - 2030 (USD million)
Figure 25. Global recombinant proteins manufacturing services market: End-user outlook and key takeaways
Figure 26. Global recombinant proteins manufacturing services market: End-user movement analysis
Figure 27. Global pharmaceutical & biotechnology companies market, 2018 - 2030 (USD million)
Figure 28. Global academic & research institutes market, 2018 - 2030 (USD million)
Figure 29. Global recombinant proteins manufacturing services market: Regional outlook and key takeaways
Figure 30. North America recombinant proteins manufacturing services market, 2018 - 2030 (USD million)
Figure 31. U.S. key country dynamics
Figure 32. U.S. recombinant proteins manufacturing services market, 2018 - 2030 (USD million)
Figure 33. Canada key country dynamics
Figure 34. Canada recombinant proteins manufacturing services market, 2018 - 2030 (USD million)
Figure 35. Europe recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 36. Germany key country dynamics
Figure 37. Germany recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 38. France key country dynamics
Figure 39. France recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 40. UK key country dynamics
Figure 41. UK recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 42. Italy key country dynamics
Figure 43. Italy recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 44. Spain key country dynamics
Figure 45. Spain recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 46. Denmark key country dynamics
Figure 47. Denmark recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 48. Sweden key country dynamics
Figure 49. Sweden recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 50. Norway key country dynamics
Figure 51. Norway recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 52. Switzerland key country dynamics
Figure 53. Switzerland recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 54. Netherlands key country dynamics
Figure 55. Netherlands recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 56. Asia-Pacific recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 57. China key country dynamics
Figure 58. China recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 59. India key country dynamics
Figure 60. India recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 61. South Korea key country dynamics
Figure 62. South Korea recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 63. Japan key country dynamics
Figure 64. Japan recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 65. Australia key country dynamics
Figure 66. Australia recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 67. Thailand key country dynamics
Figure 68. Thailand recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 69. Latin America recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 70. Brazil key country dynamics
Figure 71. Brazil recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 72. Mexico key country dynamics
Figure 73. Mexico recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 74. Argentina key country dynamics
Figure 75. Argentina recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 76. MEA recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 77. South Africa key country dynamics
Figure 78. South Africa recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 79. Saudi Arabia key country dynamics
Figure 80. Saudi Arabia recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 81. UAE key country dynamics
Figure 82. UAE recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 83. Kuwait key country dynamics
Figure 84. Kuwait recombinant proteins manufacturing services market estimates and forecast, 2018 - 2030 (USD million)
Figure 85. Market participant categorization
Figure 86. Company market share analysis, 2022
Figure 87. Strategy framework

Companies Mentioned

  • Lonza
  • Boehringer Ingelheim International GmbH
  • FUJIFILM Diosynth Biotechnologies
  • Merck KGaA
  • Bruker (InVivo BioTech Services GmbH)
  • Sino Biological, Inc.
  • GenScript
  • Kaneka Corporation (Kaneka Eurogentec S.A)
  • Polyplus Transfection (Xpress Biologics)
  • Boster Biological Technology
  • Trenzyme GmbH

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 3.48 Billion
Forecasted Market Value ( USD ) by 2030 $ 12.74 Billion
Compound Annual Growth Rate17.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Global Recombinant Proteins Market by Product (Adhesion Molecules & Receptors, Growth Factors & Chemokines, Immune Response Proteins), Services (Cloning, Expression, Purification), End-User, Function - Forecast 2023-2030 - Product Image

Global Recombinant Proteins Market by Product (Adhesion Molecules & Receptors, Growth Factors & Chemokines, Immune Response Proteins), Services (Cloning, Expression, Purification), End-User, Function - Forecast 2023-2030

  • Report
  • 191 Pages
  • Global
From
Recombinant Proteins Manufacturing Services Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031 - Product Image

Recombinant Proteins Manufacturing Services Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • Report
  • 110 Pages
  • Global
From
Recombinant Protein Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type (Growth Hormones, Interferons, Vaccines, Immunostimulating Agents, Others), By Source, By Indication, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Recombinant Protein Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type (Growth Hormones, Interferons, Vaccines, Immunostimulating Agents, Others), By Source, By Indication, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 173 Pages
  • Global
From
Global Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Research, Biopharma Production) & Region - Forecast to 2028 - Product Image

Global Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Research, Biopharma Production) & Region - Forecast to 2028

  • Report
  • 408 Pages
  • Global
From
Recombinant Proteins Manufacturing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Recombinant Proteins Manufacturing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From

About the Recombinant Proteins Manufacturing Market

The Recombinant Proteins Manufacturing market is a subset of the biopharmaceuticals industry, which focuses on the production of proteins through recombinant DNA technology. This technology involves the insertion of a gene from one organism into another, allowing for the production of proteins that are not naturally found in the organism. These proteins can be used for a variety of medical applications, such as the treatment of diseases, the development of vaccines, and the production of diagnostic tests. The Recombinant Proteins Manufacturing market is highly competitive, with a number of companies offering a range of products and services. Companies in this market include Lonza, Merck KGaA, Novozymes, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.